A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery

Nucleic Acids Research

Volumn 35, Issue 8, 2007, Pages

  Zanghi, Christine N ^a   Sapinoro, Ramil ^a   Bradel Tretheway, Birgit ^a   Dewhurst, Stephen ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; PEPTIDE; DNA; VIRUS PROTEIN;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; BACTERIOPHAGE; BACTERIOPHAGE LAMBDA; CELL LINE; GENE TARGETING; GENE TRANSFER; IMMUNOBLOTTING; IN VITRO STUDY; MACROPHAGE; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAFETY; UBIQUITINATION; VIRUS INFECTION; ANIMAL; EVALUATION; GENE VECTOR; GENETICS; METABOLISM; PROTEIN MOTIF; TRANSPORT AT THE CELLULAR LEVEL; VIRION;

ENTEROBACTERIA PHAGE LAMBDA; MAMMALIA; MURINAE;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD40; BACTERIOPHAGE LAMBDA; BIOLOGICAL TRANSPORT; CELL LINE; DNA; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MICE; VIRAL TAIL PROTEINS; VIRION;

EID: 34250332221     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm146     Document Type: Article

References (42)

1. Jepson,C.D. and March,J.B. (2004) Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine, 22, 2413-2419.
2. Chauthaiwale,V.M., Therwath,A. and Deshpande,V.V. (1992) Bacteriophage lambda as a cloning vector. Microbiol. Rev., 56, 577-591.
3. Maniatis,T., Hardison,R.C., Lacy,E., Lauer,J., O'Connell,C., Quon,D., Sim,G.K. and Efstratiadis,A. (1978) The isolation of structural genes from libraries of eucaryotic DNA. Cell, 15, 687-701.
4. Baker,M.L., Jiang,W., Rixon,F.J. and Chiu,W. (2005) Common ancestry of herpesviruses and tailed DNA bacteriophages. J. Virol., 79, 14967-14970.
5. Hoess,R.H. (2002) Bacteriophage lambda as a vehicle for peptide and protein display. Curr. Pharm. Biotechnol., 3, 23-28.
6. Eguchi,A., Akuta,T., Okuyama,H., Senda,T., Yokoi,H., Inokuchi,H., Fujita,S., Hayakawa,T., Takeda,K. et al. (2001) Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem., 276, 26204-26210.
7. Piersanti,S., Cherubini,G., Martina,Y., Salone,B., Avitabile,D., Grosso,F., Cundari,E., Di Zenzo,G. and Saggio,I. (2004) Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain. J. Mol. Med., 82, 467-476.
8. Dunn,I.S. (1996) Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. Biochimie, 78, 856-861.
9. Yang,F., Forrer,P., Dauter,Z., Conway,J.F., Cheng,N., Cerritelli,M.E., Steven,A.C., Pluckthun,A. and Wlodawer,A. (2000) Novel fold and capsid-binding properties of the lambda-phage display platform protein gpD. Nat. Struct. Biol., 7, 230-237.
10. Buchwald,M., Murialdo,H. and Siminovitch,L. (1970) The morphogenesis of bacteriophage lambda. II. Identification of the principal structural proteins. Virology, 42, 390-400.
11. Buchwald,M., Steed-Glaister,P. and Siminovitch,L. (1970) The morphogenesis of bacteriophage lambda. I. Purification and characterization of lambda heads and lambda tails. Virology, 42 375-389.
12. Casjens,S.R. and Hendrix,R.W. (1974) Locations and amounts of major structural proteins in bacteriophage lambda. J. Mol. Biol., 88 535-545.
13. Larocca,D., Kassner,P.D., Witte,A., Ladner,R.C., Pierce,G.F. and Baird,A. (1999) Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J., 13, 727-734.
14. Larocca,D., Witte,A., Johnson,W., Pierce,G.F. and Baird,A. (1998) Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum. Gene Ther., 9, 2393-2399.
15. Akuta,T., Eguchi,A., Okuyama,H., Senda,T., Inokuchi,H., Suzuki,Y., Nagoshi,E., Mizuguchi,H., Hayakawa,T. et al. (2002) Enhancement of phage-mediated gene transfer by nuclear localization signal. Biochem. Biophys. Res. Commun., 297, 779-786.
16. Eguchi,A., Furasawa,H., Yamamoto,A., Akuta,T., Hasegawa,M., Okahata,Y. and Nakanishi,M. (2005) Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles. J. Control Release 104, 507-519.
17. Zanghi,C.N., Lankes,H.A., Bradel-Tretheway,B., Wegman,J. and Dewhurst,S. (2005) A simple method for displaying recalcitrant proteins on the surface of bacteriophage lambda. Nucleic Acids Res., 33, e160.
18. Losick,V.P., Schlax,P.E., Emmons,R.A. and Lawson,T.G. (2003) Signals in hepatitis A virus P3 region proteins recognized by the ubiquitin-mediated proteolytic system. Virology, 309, 306-319.
19. Richards,J.L., Abend,J.R., Miller,M.L., Chakraborty-Sett,S., Dewhurst,S. and Whetter,L.E. (2003) A peptide containing a novel FPGN CD40-binding sequence enhances adenoviral infection of murine and human dendritic cells. Eur. J. Biochem., 270, 2287-2294.
20. Forestell,S.P., Dando,J.S., Bohnlein,E. and Rigg,R.J. (1996) Improved detection of replication-competent retrovirus. J. Virol. Methods, 60, 171-178.
21. Hudson,J.B., Misra,V. and Mosmann,T.R. (1976) Cytomegalovirus infectivity: Analysis of the phenomenon of centrifugal enhancement of infectivity. Virology, 72, 235-243.
22. O'Doherty,U., Swiggard,W.J. and Malim,M.H. (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol., 74, 10074-10080.
23. Katsura,I. (1981) Structure and function of the major tail protein of bacteriophage lambda. Mutants having small major tail protein molecules in their virion. J. Mol. Biol., 146, 493-512.
24. Maruyama,I.N., Maruyama,H.T. and Brenner,S. (1994) Lambda foo: A lambda phage vector for the expression of foreign proteins. Proc. Natl Acad. Sci. USA, 91, 8273-8277.
25. Dunn,I.S. (1996) Total modification of the bacteriophage lambda tail tube major subunit protein with foreign peptides. Gene, 183, 15-21.
26. Dunn,I.S. (1995) Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein. J. Mol. Biol., 248, 497-506.
27. Yan,Z., Zak,R., Luxton,G.W., Ritchie,T.C., Bantel-Schaal,U. and Engelhardt,J.F. (2002) Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol., 76, 2043-2053.
28. Ros,C. and Kempf,C. (2004) The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice. Virology, 324, 350-360.
29. Agarwal,S., Harada,J., Schreifels,J., Lech,P., Nikolai,B., Yamaguchi,T., Chanda,S.K. and Somia,N.V. (2006) Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proc. Natl Acad. Sci. USA, 103, 15933-15938.
30. Hicke,L. (2001) A new ticket for entry into budding vesicles-ubiquitin. Cell, 106, 527-530.
31. Katzmann,D.J., Babst,M. and Emr,S.D. (2001) Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-1. Cell, 106 145-155.
32. Warskulat,U., Zhang,F. and Haussinger,D. (1996) Modulation of phagocytosis by anisoosmolarity and betaine in rat liver macrophages (Kupffer cells) and RAW 264.7 mouse macrophages. FEBS Lett., 391, 287-292.
33. Saxena,R.K., Vallyathan,V. and Lewis,D.M. (2003) Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells. J. Biosci., 28, 129-134.
34. Tone,M., Tone,Y., Babik,J.M., Lin,C.Y. and Waldmann,H. (2002) The role of Sp1 and NF-kappa B in regulating CD40 gene expression. J. Biol. Chem., 277, 8890-8897.
35. Aki,D., Mashima,R., Saeki,K., Minoda,Y., Yamauchi,M. and Yoshimura,A. (2005) Modulation of TLR signalling by the C-terminal Src kinase (Csk) in macrophages. Genes Cells, 10, 357-368.
36. March,J.B., Clark,J.R. and Jepson,C.D. (2004) Genetic immunisation against hepatitis B using whole bacteriophage lambda particles. Vaccine, 22, 1666-1671.
37. Light,J. and Lerner,R.A. (1992) PhoPhabs: Antibody-phage-alkaline phosphatase conjugates for one step ELISA's without immunization. Bioorg. Med. Chem. Lett., 2, 1073-1078.
38. Bonnycastle,L.L., Brown,K.L., Tang,J. and Scott,J.K. (1997) Assaying phage-borne peptides by phage capture on fibrinogen or streptavidin. Biol. Chem., 378, 509-515.
39. Gao,C., Mao,S., Lo,C.H., Wirsching,P., Lerner,R.A. and Janda,K.D. (1999) Making artificial antibodies: A format for phage display of combinatorial heterodimeric arrays. Proc. Natl Acad. Sci. USA, 96, 6025-6030.
40. Chen,L., Zurita,A.J., Ardelt,P.U., Giordano,R.J., Arap,W. and Pasqualini,R. (2004) Design and validation of a bifunctional ligand display system for receptor targeting. Chem. Biol., 11, 1081-1091.
41. Uchil,P. and Mothes,W. (2005) Viral entry: A detour through multivesicular bodies. Nat. Cell. Biol., 7, 641-642.
42. Clarke,S.R. (2000) The critical role of CD40/CD40L in the CD4-dependent generation of CD8+ T cell immunity. J. Leukoc. Biol., 67, 607-614.